Christian Rommel - 30 May 2024 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role
Director
Signature
/s/ AJ Silver, attorney-in-fact
Issuer symbol
CRSP
Transactions as of
30 May 2024
Net transactions value
$0
Form type
4
Filing time
31 May 2024, 16:15:05 UTC
Next filing
06 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRSP Stock Option (Right to Buy) Award $0 +26,000 $0.000000 26,000 30 May 2024 Common Shares 26,000 $54.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on May 30, 2024 with respect to 26,000 Common Shares, with 100% of the shares vesting in 36 equal monthly installments beginning on June 30, 2024.